Internal Medicine, Interventional Cardiology · Tuscaloosa, AL
NPI
1851400485
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
100 Rice Mine Road Loop Ste 104
Tuscaloosa, AL, 35406
Phone (205) 561-2370
Groups this clinician bills Medicare through
Medicare paid, 2024
$933K
10,754 services
Medicare patients, 2024
1,710
Average age 75
Drug cost, 2024
$5.8M
13,805 prescriptions
Company payments, 2025
$3,374
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George P Hemstreet was code 93000 (electrocardiogram), 1,345 times for 952 patients. In total George P Hemstreet billed 10,754 services in 122 codes, and Medicare paid $933K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 1,345 | 952 | $8.83 | $12K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,040 | 259 | $5.66 | $5,882 |
| 93010 Electrocardiogram | Facility | 902 | 584 | $5.66 | $5,101 |
| 93306 Echocardiography (TTE/TEE) | Office | 762 | 715 | $118.29 | $90K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 520 | 259 | $83.60 | $43K |
| 93296 External Electrocardiographic Monitoring | Office | 436 | 137 | $12.36 | $5,389 |
| 93356 Echocardiography (TTE/TEE) | Office | 432 | 412 | $23.81 | $10K |
| 99232 Hospital E&M - Subsequent | Facility | 369 | 162 | $56.79 | $21K |
| 93294 External Electrocardiographic Monitoring | Office | 328 | 101 | $18.14 | $5,950 |
| 93297 External Electrocardiographic Monitoring | Office | 302 | 40 | $37.41 | $11K |
| 99214 Office E&M - Established | Office | 300 | 245 | $84.60 | $25K |
| 93298 External Electrocardiographic Monitoring | Office | 288 | 36 | $61.39 | $18K |
| 93015 Electrocardiogram | Office | 265 | 264 | $43.99 | $12K |
| 78452 Myocardial Perfusion Scan | Office | 258 | 257 | $296.16 | $76K |
| 99223 Hospital E&M - Initial | Facility | 190 | 174 | $123.08 | $23K |
By year: 2022 $1.3M for 11,124 services; 2023 $1.0M for 11,222 services; 2024 $933K for 10,754 services.
Medicare prescription drug claims, 2024
In 2024, the drug George P Hemstreet prescribed most often to Medicare patients was Clopidogrel (Clopidogrel Bisulfate), with 1,442 prescriptions and refills. In total George P Hemstreet wrote 13,805 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clopidogrel Clopidogrel Bisulfate | 1,442 | 3,507 | 429 | $18K |
| Eliquis Apixaban | 1,086 | 1,755 | 230 | $992K |
| Rosuvastatin Calcium Generic | 758 | 1,821 | 215 | $12K |
| Metoprolol Succinate Generic | 568 | 1,368 | 181 | $8,572 |
| Atorvastatin Calcium Generic | 559 | 1,427 | 158 | $7,751 |
| Losartan Potassium Generic | 468 | 1,226 | 138 | $5,638 |
| Nebivolol Hcl Generic | 367 | 846 | 107 | $24K |
| Amlodipine Besylate Generic | 362 | 898 | 116 | $1,902 |
| Carvedilol Generic | 310 | 720 | 97 | $2,628 |
| Repatha Sureclick Evolocumab | 306 | 463 | 61 | $257K |
| Pantoprazole Sodium Generic | 299 | 678 | 88 | $3,311 |
| Furosemide Generic | 299 | 630 | 99 | $1,313 |
| Entresto Sacubitril/Valsartan | 295 | 483 | 78 | $301K |
| Ranolazine Er Ranolazine | 284 | 520 | 64 | $30K |
| Bisoprolol Fumarate Generic | 273 | 692 | 75 | $11K |
Brand drugs: 3,029 claims; generic drugs: 10,776 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George P Hemstreet $3,374 ($3,374 in general payments such as food, travel and fees) from 21 companies. The largest payer was AngioDynamics, Inc. with $1,200.
| Company | Payments | Amount |
|---|---|---|
| AngioDynamics, Inc. ANGO | 1 | $1,200 |
| Bard Peripheral Vascular, Inc. BDX | 7 | $361 |
| Medtronic, Inc. MDT | 5 | $286 |
| Pfizer Inc. PFE | 14 | $240 |
| Becton, Dickinson and Company BDX | 4 | $197 |
| Novartis Pharmaceuticals Corporation NVS | 61 | $170 |
| Actelion Pharmaceuticals US, Inc. JNJ | 8 | $162 |
| Amgen Inc. AMGN | 13 | $147 |
| Novo Nordisk Inc NVO | 8 | $134 |
| Reflow Medical Inc | 7 | $120 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.